Endocrine Testing Market - Size, Share, and forecast to 2026

Endocrine Testing Market - Size, Share, and forecast to 2026

Report Description

Endocrine testing procedure consist of measuring concentration of endocrinal hormones in blood or urine. These hormones are precise marker for presence of endocrinal disease such as hypo/hyperthyroidism, infertility etc. Various endocrine glands present in body include pituitary glands, thyroid glands, hypothalamus, pancreas, and adrenal glands. Any imbalance in the hormones secreted by this glands leads to certain disorder therefore they are important marker to diagnose certain condition.

Market Dynamics
Major factor driving growth of the endocrine testing market is increasing prevalence of endocrinal disease which requires first point diagnosis. Cushing syndrome is one of major endocrinal disorder. Cushing syndrome is result of the excess exposure to hormone cortisol. Cortisol concentration may elevate due to longer treatment of chronic asthma or rheumatoid arthritis and other causes. According to American Association of Neurological Surgeon statistics, around 10-15 per million people are affected by Cushing syndrome every year. Prevalence of postmenopausal osteoporosis is high, owing to low production of estradiol in women. According to International Osteoporosis Foundation factsheet, around 30% of all postmenopausal women have osteoporosis in the US and in Europe. Among them, 40% of women suffer from one or more fragility fractures in their lifetime. Increasing ageing population is also expected to aid in growth of the endocrine testing market, owing to high prevalence of endocrinal disease. According to population Prospect report by United Nations in 2017, an estimated 962 million people are aged 60 or above in the world, which accounted for 13% of the global population. The number of older people in the world is projected to be 1.4 billion growing at annual rate of 3% by 2030.
Key features of the study:

• This report provides in-depth analysis of endocrine testing market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new Fixator launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global endocrine testing market based on the following parameters – company overview, financial performance, Fixator portfolio, market presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Abbott Laboratories, Thermo Fisher Scientific, Beckman Coulter, Inc., Siemens Healthineers, bioMérieux SA, Agilent Technologies, Bi-Rad Laboratories, AB Sciex, F-Hoffmann La Roche AG, Quest Diagnostics and others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future fixator launch, technology up-gradation, market expansion, and marketing tactics
• The global endocrine testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the endocrine testing market

Detailed Segmentation:

• Global Endocrine Testing Market, By Product:
• Thyroid
• Insulin
• Follicle Stimulating Hormone
• Luteinizing Hormone
• Estradiol
• Testosterone
• Progesterone
• Human chorionic gonadotropin
• Prolactin
• Cortisol
• DHEA-S
• Others
• Global Endocrine Testing Market, By Diagnostic Technology :
• Immunoassay
• Tandem Mass Spectroscopy
• Monoclonal AND Polyclonal Antibody
• Sensor Technologies
• Clinical Chemistry
• Others
• Global Endocrine Testing Market, By End User:
• Hospitals
• Diagnostic Laboratories
• Others
• Global Endocrine Testing Market, By Region:
• North America Endocrine Testing Market
• By Test
• Thyroid
• Insulin
• Follicle Stimulating Hormone
• Luteinizing Hormone
• Estradiol
• Testosterone
• Progesterone
• Human chorionic gonadotropin
• Prolactin
• Cortisol
• DHEA-S
• Others
• By Diagnostic Technology
• Immunoassay
• Tandem Mass Spectroscopy
• Monoclonal AND Polyclonal Antibody
• Sensor Technologies
• Clinical Chemistry
• Others
• By End User:
• Hospitals
• Diagnostics Laboratories
• Others
• By Country:
• U.S.
• Canada
• Latin America Endocrine Testing Market
• By Test
• Thyroid
• Insulin
• Follicle Stimulating Hormone
• Luteinizing Hormone
• Estradiol
• Testosterone
• Progesterone
• Human chorionic gonadotropin
• Prolactin
• Cortisol
• DHEA-S
• Others
• By Diagnostic Technology
• Immunoassay
• Tandem Mass Spectroscopy
• Monoclonal AND Polyclonal Antibody
• Sensor Technologies
• Clinical Chemistry
• Others
• By End User:
• Hospitals
• Diagnostics Laboratories
• Others
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe Endocrine Testing Market
• By Test
• Thyroid
• Insulin
• Follicle Stimulating Hormone
• Luteinizing Hormone
• Estradiol
• Testosterone
• Progesterone
• Human chorionic gonadotropin
• Prolactin
• Cortisol
• DHEA-S
• Others
• By Diagnostic Technology
• Immunoassay
• Tandem Mass Spectroscopy
• Monoclonal AND Polyclonal Antibody
• Sensor Technologies
• Clinical Chemistry
• Others
• By End User:
• Hospitals
• Diagnostics Laboratories
• Others
• By Country:
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific Endocrine Testing Market
• By Test
• Thyroid
• Insulin
• Follicle Stimulating Hormone
• Luteinizing Hormone
• Estradiol
• Testosterone
• Progesterone
• Human chorionic gonadotropin
• Prolactin
• Cortisol
• DHEA-S
• Others
• By Diagnostic Technology
• Immunoassay
• Tandem Mass Spectroscopy
• Monoclonal AND Polyclonal Antibody
• Sensor Technologies
• Clinical Chemistry
• Others
• By End User:
• Hospitals
• Diagnostics Laboratories
• Others
• By Country:
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East Endocrine Testing Market
• By Test
• Thyroid
• Insulin
• Follicle Stimulating Hormone
• Luteinizing Hormone
• Estradiol
• Testosterone
• Progesterone
• Human chorionic gonadotropin
• Prolactin
• Cortisol
• DHEA-S
• Others
• By Diagnostic Technology
• Immunoassay
• Tandem Mass Spectroscopy
• Monoclonal AND Polyclonal Antibody
• Sensor Technologies
• Clinical Chemistry
• Others
• By End User:
• Hospitals
• Diagnostics Laboratories
• Others
• By Country:
• GCC
• Israel
• Rest of Middle East
• Africa Endocrine Testing Market
• By Test
• Thyroid
• Insulin
• Follicle Stimulating Hormone
• Luteinizing Hormone
• Estradiol
• Testosterone
• Progesterone
• Human chorionic gonadotropin
• Prolactin
• Cortisol
• DHEA-S
• Others
• By Diagnostic Technology
• Immunoassay
• Tandem Mass Spectroscopy
• Monoclonal AND Polyclonal Antibody
• Sensor Technologies
• Clinical Chemistry
• Others
• By End User:
• Hospitals
• Diagnostics Laboratories
• Others
• By Country:
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Abbott Laboratories*
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
• Thermo Fisher Scientific
• Bi-Rad Laboratories
• Beckmann Coulter, Inc.
• Agilient Technologies
• Siemens Healthineers
• bioMérieux SA
• Quest Diagnostics
• F-Hoffmann La Roche AG

“*” marked represents similar segmentation in other categories in the respective section.